PerMe

Deep Tech Digital Health Platform for DNA Testing

Health Tech & Life Sciences
Active
Pre-Seed Herzliya, Israel Founded 2022
Last updated 2026-06-18
Total raised
$2.0M
Last: 2025-01
Stage
Pre-Seed
Founded
2022
Headcount
14
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

PERME is a deep-tech digital health platform that develops disruptive innovation in home testing with a Novel IP. PERME converts biological samples to digital information in real-time with an affordable device no labs need.

With a market potential surpassing $500 billion, its innovative approach is guided by experts in nanotechnology, MEMS (Micro-Electro-Mechanical Systems), longevity, genetics, RF engineering, bioinformatics, and tech entrepreneurs.

The company's software initially converts biological data into digital output resulting in health recommendations and telehealth consultations.. Applying advanced data analytics and AI/ML on the big data PerMe is collecting, will be the heart of healthcare innovation, understanding complex diseases and discovering new medicines.

Funding history · 2 rounds · $2.0M total

2025-01
Undisclosed
2024-09
Undisclosed

Q&A

What is PerMe's primary focus?
PerMe is a deep-tech digital health platform that develops disruptive innovation in home DNA testing, converting biological samples to digital information in real-time with an affordable device that does not require labs.
When was PerMe founded?
PerMe was founded in May 2022.
Who are the founders of PerMe?
The founders of PerMe are Yoav Rapaport (Founder & CEO) and Igal Chertkow (Founder & CTO).
What is PerMe's current funding stage?
PerMe is currently in the Pre-Seed funding stage.
Which investors participated in PerMe's January 2025 funding round?
Rhodium participated in PerMe's funding round in January 2025.
Which investors participated in PerMe's September 2024 funding round?
IL Angel Club participated in PerMe's funding round in September 2024.
What technologies does PerMe utilize in its platform?
PerMe utilizes Artificial Intelligence and Machine Learning in its platform.

Team · 2

Founder · Founder & CEO
LinkedIn ↗
Founder · Founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Tags

testingdigital-healthcarebiotechnologyremote-monitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepermedna.com/
LinkedInlinkedin.com/company/88676302

Identifiers & details

Founded2022-5
Employees (exact)14

Radar intelligence

Patents

EPO2

Publications (Crossref)

Works8

Web history (Wayback)

Domainpermedna.com

Certificate / subdomain footprint

Subdomains5